drugset / Trial / NCT01253642

Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel

NCT01253642

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies how well giving phenelzine sulfate together with docetaxel works in treating patients with prostate cancer that is growing, spreading, or getting worse after first-line therapy with docetaxel. Phenelzine sulfate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Phenelzine sulfate may also help docetaxel work better by making tumor cells more sensitive to the drug. Giving phenelzine sulfate together with docetaxel may kill more tumor cells.

Timeline

Start
2010-07-12
Primary completion
2016-09-15
Completion
2017-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenelzine Small molecule Oral
Background Docetaxel Small molecule Intravenous